UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of ~~December~~February ~~2025 (Report No. 2)~~2026

Commission File Number: 001-40614

INTERCURE LTD.

(Translation of registrant’s name into English)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On ~~December~~February 3019, ~~2025~~2026, ~~an Annual General Meeting of Shareholders of~~ InterCure Ltd. (the “~~Company~~Registrant”) ~~approved~~issued ~~each~~a ofpress ~~the~~release ~~four proposals~~titled ~~brought~~“InterCure ~~before~~Announces ~~the~~Preliminary ~~Company’s shareholders at the meeting, in accordance with the majority required for each proposal.~~Estimated ~~Each~~2025 Revenue of ~~those~~NIS ~~proposals~~265 ~~was~~Million, ~~described~~Positive inAdjusted ~~the~~EBITDA ~~Company’s Notice~~ and ~~Proxy~~Cash ~~Statement~~of ~~with~~NIS ~~respect~~43 toMillion,” ~~the Company’s Annual General~~a ~~Meeting~~copy of ~~Shareholders,~~which ~~dated~~is ~~November~~furnished ~~25, 2025, attached~~ as Exhibit 99.1 towith ~~the~~this ~~Company’s~~report ~~Form~~of ~~6-K~~Foreign ~~that~~Private ~~was~~Issuer ~~furnished to the U.S. Securities and Exchange Commission~~ on ~~November~~Form ~~25, 2025~~6-K.

Exhibit No.
99.1		Press Release issued by InterCure Ltd. on February 19, 2026, titled “InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million.”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTERCURE LTD.
Date: December 30, 2025	/s/ Amos Cohen
Date: February 19, 2026	/s/ Amos Cohen
	Amos Cohen Chief Financial Officer
	Amos Cohen
	Chief Financial Officer

Filing Compare · Intercure Ltd.